U.S. panel rejects most of Philip Morris' iQOS tobacco device claims

WASHINGTON (Reuters) - Philip Morris International Inc should not be allowed to claim that its iQOS electronic tobacco device can reduce the risk of tobacco-related diseases, an advisory panel to the U.S. Food and Drug Administration concluded on Thursday.

U.S. panel rejects most of Philip Morris' iQOS tobacco device claims
Read More


Bagikan Berita Ini